We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
+$5B
Cap. Flow %
0.82%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.11%
2 Technology 2.38%
3 Consumer Discretionary 1.48%
4 Healthcare 0.92%
5 Communication Services 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
10676
PUT
DELISTED
Acorda Therapeutics
ACOR
$52K ﹤0.01%
+628
New +$57.7K
RDI icon
10677
CALL
Reading International Class A
RDI
$48.1M
$51K ﹤0.01%
+10,100
New +$35.3K
REFR icon
10678
CALL
Research Frontiers
REFR
$16.9M
$51K ﹤0.01%
18,000
+2,100
+13% +$5.93K
RKDA icon
10679
PUT
Arcadia Biosciences
RKDA
$1.24M
$51K ﹤0.01%
+506
New +$61.8K
STGW icon
10680
Stagwell
STGW
$2.17B
$51K ﹤0.01%
+20,128
New +$44.9K
TOUR
10681
PUT
Tuniu
TOUR
$51.5M
$51K ﹤0.01%
+2,880
New +$47.7K
BMRA icon
10682
Biomerica
BMRA
$6.49M
$50K ﹤0.01%
1,263
-491
-28% -$24.6K
IMDX
10683
CALL
Insight Molecular Diagnostics
IMDX
$140M
$50K ﹤0.01%
+1,045
New +$38.3K
RNAC icon
10684
Cartesian Therapeutics
RNAC
$302M
$50K ﹤0.01%
547
+152
+38% +$13.2K
ORKA
10685
PUT
Oruka Therapeutics
ORKA
$6.39B
$50K ﹤0.01%
+1,042
New +$51.9K
BBW icon
10686
CALL
Build-A-Bear
BBW
$357M
$49K ﹤0.01%
+11,400
New +$43.9K
UAMY icon
10687
United States Antimony
UAMY
$772M
$49K ﹤0.01%
93,949
+67,022
+249% +$27.3K
ACOR
10688
CALL
DELISTED
Acorda Therapeutics
ACOR
$49K ﹤0.01%
591
+210
+55% +$19.3K
SMHI icon
10689
SEACOR Marine Holdings
SMHI
$258M
$48K ﹤0.01%
+17,564
New +$37.2K
ACGN
10690
DELISTED
Aceragen Inc
ACGN
$48K ﹤0.01%
+767
New +$44K
SREV
10691
DELISTED
ServiceSource International, Inc.
SREV
$48K ﹤0.01%
27,428
+10,627
+63% +$15.7K
LEJU
10692
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$48K ﹤0.01%
+2,081
New +$49K
RRD
10693
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$48K ﹤0.01%
+21,100
New +$31.7K
GGB icon
10694
Gerdau
GGB
$9.22B
$47K ﹤0.01%
12,716
-6,098
-32% -$20.3K
LCTX icon
10695
PUT
Lineage Cell Therapeutics
LCTX
$293M
$47K ﹤0.01%
+26,500
New +$37.1K
ANH
10696
CALL
DELISTED
Anworth Mortgage Asset Corporation
ANH
$47K ﹤0.01%
17,200
-33,800
-66% -$70.2K
MTL
10697
CALL
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$47K ﹤0.01%
+23,000
New +$36.3K
EFOI icon
10698
CALL
Energy Focus
EFOI
$18.5M
$46K ﹤0.01%
1,614
-700
-30% -$29K
SXC icon
10699
PUT
SunCoke Energy
SXC
$873M
$46K ﹤0.01%
10,600
-10,600
-50% -$44.4K
TTNP
10700
PUT
DELISTED
Titan Pharmaceuticals
TTNP
$46K ﹤0.01%
+705
New +$55.7K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.